Updated Q3 2026 by CT Acquisitions.

Venture capital vs growth equity: the LMM operator’s 2026 guide

If you run a profitable operating business and you are weighing venture capital vs growth equity, the honest answer is that these two capital sources almost never bid against each other for the same deal. Venture capital funds pre-profit companies chasing power-law outcomes in software, life sciences, or frontier tech, and it rewards founders willing to trade control for a shot at a 20x return. Growth equity funds profitable, growing companies (usually $3M to $50M in revenue growth per year, often $5M to $50M EBITDA) with minority checks that leave the operator in the driver’s seat. If you generate real cash flow and you are looking to accelerate hiring, buy a competitor, or partially cash out while staying at the helm, growth equity is the right lane, not venture capital.

This guide is written for lower middle market operators (revenue $3M to $50M and up, EBITDA $1M to $25M) who have started fielding inbound calls from investors and want a straight framework before signing an NDA. Every claim is grounded in 2024-2026 deal data, every capital source is named, and every fee, dilution range, and timeline reflects what CT Acquisitions is seeing on live LMM mandates this quarter.

What is venture capital vs growth equity in plain English?

Venture capital funds pre-profit companies (usually pre-Series-C) that are burning cash to capture a market, buying minority stakes in exchange for outsized ownership and heavy governance rights. Growth equity funds already-profitable companies (or those with clear near-term profitability) that need capital to accelerate hiring, launch new products, or fund acquisitions, again in minority form but with lighter governance and less punitive preference stacks. Sequoia is VC; TA Associates is growth equity.

The clearest way to separate the two categories is by the profile of the target company, not by fund label alone. Venture capital, per the NVCA Yearbook 2025, deploys into companies where product-market fit is still being proven, revenue is often under $10M, and gross burn is normal. Growth equity, per PitchBook’s Q1 2025 Growth Equity Report, deploys into companies with $10M plus in ARR, positive EBITDA or a near-term path to it, and a track record of predictable expansion.

The overlap zone (late-stage VC and early growth equity) is real but narrower than most operators assume. Insight Partners, ICONIQ Growth, and General Atlantic run books across both categories, but the deals they close in each lane have distinctly different economics. A $50M Insight round into a $12M ARR profitable vertical SaaS is a growth equity deal in everything but the fund’s own marketing materials. A $50M Insight round into a $4M ARR AI infrastructure startup burning $2M a month is late-stage VC by every meaningful metric.

For an LMM operator generating real EBITDA, this distinction matters enormously. A VC fund underwriting to a power-law outcome will push you to spend faster, hire aggressively, and chase market share at the expense of margin. A growth equity fund underwriting to a 3x to 5x MOIC over five years will pressure you to preserve profitability while accelerating growth, and will structure the term sheet accordingly (lighter preference stack, less onerous protective provisions, board composition that reflects a partnership rather than a takeover).

Who typically raises venture capital vs growth equity?

Venture capital targets founders of pre-profit technology, life sciences, and frontier-tech companies where the total addressable market justifies a 10x to 20x return underwrite. Growth equity targets operators of profitable, growing companies in software, tech-enabled services, healthcare, and consumer where a 3x to 5x MOIC over five years is realistic. If your business generates $2M plus in EBITDA and grows 15 percent plus organically, you are a growth equity target, not a venture capital target.

Concrete company profiles clarify the split. A pre-revenue biotech spinout of Stanford developing a novel CAR-T therapy is a textbook Series A VC target, and Third Rock Ventures, Flagship Pioneering, or ARCH Venture Partners would be the natural funders per Silicon Valley Bank’s 2025 State of the Markets Report. A $9M ARR vertical SaaS company serving dental practices, growing 40 percent year over year with 25 percent EBITDA margins and 110 percent net revenue retention, is a textbook growth equity target, and Mainsail Partners, Silversmith Capital, or Level Equity would be the natural funders per Mainsail’s portfolio profile.

The gray zone that creates the most confusion is founder-led profitable software companies in the $2M to $10M ARR range. These businesses receive inbound outreach from both categories, and the difference in what each capital source will offer is stark. A Series B VC round would push aggressive burn and dilute the founder to 40 percent. A growth equity minority round would preserve founder control at 60 to 80 percent, add board seats reflecting the ownership split, and structure the incentive plan to reward disciplined growth rather than pure velocity.

CT Acquisitions works primarily with the second category, which is why our lower middle market advisor practice is built around structuring processes for owners who want capital and a partner without giving up the company. For a granular view of the LMM sponsor universe, see our guide on growth equity vs private equity.

How does venture capital vs growth equity compare on core deal terms?

Growth equity term sheets typically feature 1x non-participating preferred, weighted-average anti-dilution, a single investor board seat, and standard protective provisions. Late-stage VC term sheets often add participating preferred, multi-turn liquidation preferences in stressed markets, full-ratchet anti-dilution, and stronger protective provisions covering budget approval, hiring at the C-suite level, and any change in strategy. On a $30M raise, the difference in preference stack alone can move founder proceeds by $8M to $12M in a mid-case exit.

The economics live in the fine print, and every LMM operator should model the waterfall under a range of exit scenarios before signing. The most common trap in 2024-2026 term sheets from any capital source is the participating preferred structure, which allows the investor to first take back their original capital as a preference and then also participate in the common equity distribution pro rata to their ownership. In a $200M exit on a $30M growth round at $150M pre-money, non-participating preferred returns roughly $33M to the investor. Participating preferred with a 1x preference returns roughly $53M, a 60 percent uplift to the investor and a matching reduction to the founder.

Term	Typical Late-Stage VC (Series B/C)	Typical LMM Growth Equity
Company stage	Pre-profit or breakeven, high burn	Profitable, positive EBITDA, low or no burn
Check size range	$10M to $150M	$10M to $75M (LMM segment)
Ownership taken	15% to 40%	15% to 35%
Board seats	1 to 2 investor seats, often with observer	1 investor seat, occasionally observer
Liquidation preference	1x non-participating standard, participating common in soft markets	1x non-participating standard
Anti-dilution	Broad-based weighted average; full ratchet in stressed rounds	Broad-based weighted average
Protective provisions	Extensive: budget, hiring, strategy, M&A, debt	Focused: M&A, debt above threshold, sale of company
Underwriting target	10x plus MOIC on winners	3x to 5x MOIC portfolio target
Hold period	5 to 10 years	4 to 6 years
Exit expectation	IPO or strategic sale to public acquirer	Sale to larger PE fund or strategic; occasional IPO

The market data reinforces the split. Per PitchBook’s Q4 2024 US VC Valuations Report, median Series C pre-money valuation was $85M against $18M median ARR (roughly 4.7x forward revenue), while median growth equity round pre-money was $145M against $28M median ARR (roughly 5.2x forward revenue). The multiples look similar, but the underlying company profiles (growth rate, gross margin, burn) are meaningfully different.

When does venture capital vs growth equity actually make sense?

Venture capital makes sense when the company has a defensible product but has not yet reached profitability, and where the founding team is willing to trade meaningful control for the capital to reach an outsized exit. Growth equity makes sense when the company already generates positive EBITDA (or breakeven with clear line of sight), the operator wants to preserve day-to-day control, and there is a specific growth investment thesis (hiring, M&A, geography, product) that capital would accelerate but is not existential.

A practical decision framework for the LMM operator looks at four factors. First, current profitability: if EBITDA is positive and growing, growth equity is almost always cleaner than VC. Second, growth rate: sustainable 20 to 40 percent organic growth is the growth equity sweet spot per Bain & Company’s 2025 Global Private Equity Report. Above 60 percent with heavy burn tilts back toward late-stage VC. Third, use of proceeds: if capital funds M&A, sales team scaling, or a defined product expansion, growth equity fits. If capital funds a bet on new market creation, VC fits. Fourth, founder control preference: if you want to keep the CEO seat and majority ownership, growth equity; if you accept CEO transitions and majority dilution in exchange for platform-level support, later-stage VC.

Concrete 2024-2026 comps illustrate the fit. Mainsail Partners’ 2024 investment in Officetrax, a facilities management SaaS, was a classic LMM growth equity deal: profitable company, minority stake, no leverage, board seat, founder retained control. Compare that to Andreessen Horowitz’s 2024 lead of Poolside’s Series B (reported at $500M into a pre-revenue AI coding assistant per Reuters): pre-revenue, majority dilution, aggressive burn plan, board control shift. Both are legitimate financings; they solve entirely different capital problems.

How much does venture capital vs growth equity actually cost the founder?

The headline cost is dilution: 15 to 35 percent for LMM growth equity, 20 to 40 percent for late-stage VC per round. The hidden cost is the preference stack in downside scenarios. In a soft exit at 1.5x invested capital, participating preferred VC terms can leave the founder with 30 to 45 percent less proceeds than a clean non-participating growth equity structure. Advisor and legal fees typically add 3 to 6 percent of gross proceeds on either side.

Cost category	Late-Stage VC	LMM Growth Equity
Founder dilution per round	20% to 40%	15% to 35%
Placement agent / advisor fee	2% to 5% of raise (often waived for top-tier)	2% to 5% of raise
Legal fees (both sides)	$500K to $1.5M on a $30M raise	$400K to $1M on a $30M raise
Investor legal reimbursement	$150K to $400K cap common	$100K to $300K cap common
Diligence / QoE	Investor pays, founder time cost 200 to 400 hours	Investor pays, founder time cost 150 to 300 hours
Preference cost in 1.5x exit	30% to 45% haircut to common with participating pref	0% to 5% haircut with clean 1x non-participating
Option pool refresh	10% to 15% pre-money (dilutes founder)	5% to 10% pre-money
Board / governance overhead	10 to 15 hours per month CEO time	5 to 10 hours per month CEO time
Total transaction timeline	3 to 5 months	4 to 6 months

Modeling the true cost requires running the exit waterfall under multiple scenarios. On a $200M exit outcome after a $30M growth equity round at $150M pre-money, a clean 1x non-participating preferred returns the investor roughly 16.5 percent IRR over five years and preserves 83 percent of founder equity. On the same $200M exit outcome after a $30M late-stage VC round at $120M pre-money with 1x participating preferred and a 15 percent option pool refresh, the investor returns closer to 22 percent IRR and the founder is left with 62 percent of their pre-round equity, a difference of roughly $42M in this specific scenario. This is the math the term sheet negotiation is really about.

Who provides venture capital vs growth equity to LMM operators?

The LMM growth equity market is served by 40 or so named funds writing $5M to $75M checks into profitable, growing companies. The late-stage VC market is served by roughly 60 tier-one franchises writing $20M plus checks into pre-profit growth companies. Family offices and structured-capital providers fill the gap for LMM operators who want minority capital with even less governance than either category. Below is a working list of the funds most active in each lane in 2024-2026.

Firm	Category	Typical check	LMM sweet spot
Mainsail Partners	Growth equity	$15M to $50M	Bootstrapped B2B software, $5M+ ARR, 20%+ growth
Susquehanna Growth Equity	Growth equity	$25M to $75M	SaaS, tech-enabled services, financial technology
Silversmith Capital Partners	Growth equity	$20M to $75M	Growth-stage software and healthcare tech
Rubicon Technology Partners	Growth equity / buyout	$25M to $150M	Enterprise software with recurring revenue
Frontier Growth	Growth equity	$10M to $30M	B2B SaaS, $3M to $30M ARR
Level Equity	Growth equity	$15M to $75M	Founder-led software and tech-enabled services
Serent Capital	Growth equity / buyout	$20M to $75M	Business services and vertical software
JMI Equity	Growth equity	$25M to $150M	Application software, $10M+ ARR
PSG Equity	Growth equity	$25M to $200M	Middle-market software, $10M+ ARR
TA Associates	Growth equity	$50M to $500M	Later-stage LMM to middle market
General Atlantic	Late-stage growth	$50M to $500M	Global growth companies with scale
Insight Partners	Growth equity / late VC	$25M to $500M	Software across stages, spans both categories
Andreessen Horowitz	Venture capital	$5M to $500M	Consumer, enterprise, crypto, bio at all stages
Sequoia Capital	Venture capital	$1M to $250M	Seed to growth in technology and healthcare
Bessemer Venture Partners	Venture capital	$5M to $150M	Cloud, consumer, healthcare, financial services
Accel	Venture capital	$5M to $75M	Enterprise and consumer at early growth stages

For LMM operators specifically, the growth equity funds most worth knowing are the ones with dedicated LMM sub-funds or programs. Mainsail Partners closed Fund VII at $1.15B in 2024, targeting bootstrapped B2B software companies with $5M plus ARR. Frontier Growth closed Fund VI at $525M in 2024, focused on $3M to $30M ARR SaaS. Silversmith closed Fund IV at $1.55B in 2024. These fund closes indicate a durable pool of LMM growth capital even after the 2022-2023 valuation reset.

Family offices increasingly compete for the same deals with looser terms. In our experience running LMM processes at CT Acquisitions, family-office bidders will accept less operational involvement, longer hold periods (7 to 10 years versus 4 to 6), and rarely insist on control provisions like consent rights over M&A under a $10M threshold. For the tradeoffs involved, see our comparison of family office vs PE buyer.

How does the venture capital vs growth equity process actually work?

A well-run LMM growth equity or late-stage VC process follows nine to ten sequenced steps over four to six months. The steps are advisor selection, materials preparation, target list build, teaser outreach, first-round meetings, IOI collection, management presentations, confirmatory diligence, term-sheet negotiation, and legal close. Skipping steps or compressing the timeline consistently produces worse economic and governance outcomes.

1. Advisor selection (weeks 1 to 2): Interview two to four sell-side or capital-raise advisors. Compare sector coverage, buyer list quality, prior deal comps in your revenue range, and fee structures. Boutique investment banks typically charge a 3 to 5 percent success fee on the transaction with a $50K to $150K retainer credited against success.
2. Materials preparation (weeks 3 to 6): Advisor and management build the confidential information memorandum (CIM), management presentation, virtual data room, and financial model. The CIM anchors valuation expectations. A weak CIM caps offers.
3. Target list build (weeks 3 to 5): Advisor builds a 40 to 80 name target list, filtering by check size, sector fit, structural preferences (minority vs control, primary vs secondary), and prior process behavior. The target list is the single most consequential decision in the process.
4. Teaser outreach (weeks 6 to 8): Blind one-page teaser goes to the target list under NDA. Interested parties execute an NDA and receive the CIM. Response rate on a well-targeted list runs 40 to 60 percent, generating 20 to 40 CIM recipients.
5. First-round management meetings (weeks 9 to 12): Advisor coordinates two-hour Zoom or in-person management presentations with 8 to 15 sponsors. Founders should expect follow-up diligence requests and preliminary questions on structure preference.
6. IOI collection (week 13): Advisor collects indications of interest specifying enterprise value range, structure, primary vs secondary split, governance ask, and closing timeline. Typical IOI count on a well-run process is 5 to 10 written bids.
7. Second-round diligence (weeks 14 to 16): Top 3 to 5 sponsors get access to the full data room, additional management sessions, and customer references. This is where soft bids get retracted or firmed up.
8. Term-sheet negotiation (weeks 17 to 20): Advisor runs the term sheet negotiation in parallel with the top 2 to 3 sponsors, pressuring not just on valuation but on preference stack, board composition, protective provisions, and management agreements. Signing an exclusive letter of intent (LOI) ends the auction, so timing matters.
9. Confirmatory diligence (weeks 21 to 24): Under exclusivity, the selected sponsor completes financial, legal, tax, commercial, technology, and HR diligence. Founders should expect a QoE (quality of earnings) study, customer survey, and technology architecture review.
10. Legal close (weeks 21 to 26, in parallel): Definitive purchase agreement, shareholders’ agreement, registration rights agreement, and management employment agreements are negotiated and executed. Funds flow at close.

For a deeper read on the seller-side mechanics that apply symmetrically to a capital raise, see our guide on selling to a growth equity investor. For the term-sheet documents themselves, our reference on what is a term sheet unpacks every provision commonly seen in an LMM growth round.

What paperwork and documentation does a venture capital vs growth equity raise require?

A well-prepared LMM growth equity raise requires roughly 200 to 400 documents organized across 12 to 18 data room folders. The core documents are three years of audited or reviewed financials, monthly management reporting for 24 months, top 20 customer contracts, cap table with option ledger, corporate charter and bylaws, board minutes, key employee agreements, and IP assignments. Weak documentation extends the diligence period and gives investors negotiating power.

The virtual data room is the operating manual for the diligence phase. Sponsors like TA Associates, JMI Equity, and PSG Equity run structured diligence checklists that touch every part of the business. A typical folder structure includes: corporate documents, financial statements and audits, tax returns and filings, customer contracts and metrics, employee agreements and comp plans, IP registrations and assignments, real estate leases, insurance policies, litigation history, regulatory filings, technology architecture and security, and cyber and data privacy.

For LMM operators who have never been through this process, the two biggest documentation gaps we see at CT Acquisitions are inadequate customer contract organization (many operators have signed contracts stored in emails or founder inboxes rather than a system of record) and stale cap tables that do not reflect the actual option grants, vesting schedules, and any prior SAFEs or convertible notes. Fixing both gaps before launch prevents the two most common late-stage deal breakers.

A quality of earnings study, commissioned by the founder rather than the investor, materially strengthens the negotiating position. Sponsors will still commission their own QoE, but leading with a prepared sell-side QoE anchors the earnings baseline. Firms like RSM, BDO, and CohnReznick typically charge $50K to $150K for an LMM sell-side QoE.

What are the tax and legal implications of a growth equity or VC round?

A primary growth equity round is generally non-taxable to the founder because no shares are sold. A secondary component (founder liquidity) is a taxable sale of stock, typically eligible for long-term capital gains treatment if held over one year, with QSBS Section 1202 exclusion of up to $10M per shareholder possible for qualifying C-corps held over five years. State tax treatment varies significantly, and Delaware C-corp structure remains the near-universal standard for institutional equity rounds.

The most valuable tax planning lever for founders is Section 1202 Qualified Small Business Stock (QSBS). If your company is a Delaware C-corp, has gross assets under $50M at the time you acquired your stock, and you have held the stock over five years, you can exclude up to the greater of $10M or 10x your basis in gains from federal tax on a sale. For LMM founders selling a partial secondary in a growth equity round, this can eliminate federal tax on up to $10M of gain per person and per issuer, subject to the qualifying rules.

The One Big Beautiful Bill Act (OBBBA) signed into law in 2025 preserved QSBS and made favorable modifications for issuances after July 4, 2025, including an accelerated partial exclusion at three and four years of holding, expansion of the per-issuer cap to $15M for post-enactment stock, and a lift of the gross-assets ceiling to $75M per Pillsbury’s legal analysis. Operators contemplating a partial secondary in 2026 or 2027 should model the tax impact under both the legacy and new rules with their tax advisor.

On the legal side, the transaction documents are meaningfully more complex than a typical LLC or S-corp financing. Every LMM growth equity round involves at minimum a stock purchase agreement, an amended and restated certificate of incorporation, an amended and restated shareholders agreement (with drag-along, tag-along, right of first refusal, and preemptive rights), a registration rights agreement, a voting agreement, and updated employment agreements for the founding team. Total legal cost on both sides typically runs $400K to $1M on a $30M raise, higher for cross-border complexity.

What are the common structures and terms in a venture capital vs growth equity round?

The near-universal structure is preferred stock with 1x non-participating liquidation preference, broad-based weighted-average anti-dilution, standard protective provisions, and pay-to-play optional. Growth equity rarely uses multi-turn preferences or full-ratchet anti-dilution in normal markets. Late-stage VC in a stressed round may add participating preferred, senior tranches, and structured PIK preferences that quietly compound returns to the investor while diluting common equity.

The provisions that most affect founder outcomes in a mid-case exit are liquidation preference, participation rights, and anti-dilution. Liquidation preference of 1x non-participating means the investor gets their money back first and then chooses between keeping the preference or converting to common and taking pro rata. Participating preferred means the investor takes the preference and also participates in the common distribution. In a soft exit, participating preferred can materially reduce common proceeds; the difference between 1x non-participating and 1x participating on a $30M round in a $75M exit is roughly $22M vs $34M to the investor.

Anti-dilution protects the investor if the company raises a subsequent round at a lower valuation. Broad-based weighted average is the market standard and adjusts the conversion price modestly. Full ratchet adjusts the investor’s conversion price to match the lower round price, materially diluting founder and employee equity. In 2024-2026 term sheets we have reviewed, full ratchet appears occasionally in structured or bridge situations but rarely in a primary growth equity round from a reputable sponsor.

Protective provisions are the investor’s veto rights over specific corporate actions. LMM growth equity term sheets typically limit these to sale of the company, M&A above a threshold ($5M to $10M), debt incurrence above a threshold, changes to the charter or preferred stock rights, and issuance of senior or pari passu equity. Late-stage VC often expands the list to include annual budget approval, hiring of C-suite executives, geographic expansion, and material changes to strategy, meaningfully constraining the CEO’s operating freedom.

What are the biggest red flags in a venture capital vs growth equity term sheet?

Watch for participating preferred stock, multi-turn liquidation preferences, full-ratchet anti-dilution, punitive drag-along thresholds (below 50 percent investor consent), broad protective provisions covering budget and hiring, and mandatory management option pool refreshes buried in the term sheet as a pre-money adjustment. Any one of these can quietly transfer 5 to 25 percent of eventual exit proceeds from the founder to the investor without changing the headline valuation.

The option pool refresh trap deserves particular attention. Investors typically require the pre-money valuation to include a fully-diluted option pool sized to cover future hiring for 18 to 24 months. If the current pool has 5 percent unallocated and the investor requires 15 percent unallocated at close, the incremental 10 percent comes entirely out of the founders’ pre-money ownership. On a $150M pre-money at 20 percent dilution, this shifts roughly $15M of value from founder to a future-hires option pool. Negotiating pool size and post-money adjustment is more valuable than negotiating the headline pre-money.

Drag-along provisions determine when the investor can force a sale of the company. A founder-friendly drag requires majority approval of both preferred and common. An investor-friendly drag requires only majority approval of preferred, meaning the investor can force a sale even if the founders and management team oppose it. In 2024-2026 LMM growth equity deals we have reviewed, the market standard has held at majority-of-preferred with a floor return protection for common, but exceptions exist and matter.

Board composition sets the day-to-day governance dynamic. A typical LMM growth equity board post-close is five seats: two founder/management, two investor, and one mutually-agreed independent. Structures that give the investor three of five seats (or that give the investor unilateral control of the independent seat) tilt the governance dynamic materially and are worth pushing back on. For a broader look at governance tradeoffs across capital sources, our guide on growth equity vs private equity covers this in depth.

What are the 2024-2026 market dynamics for venture capital vs growth equity?

Growth equity dry powder sits near record highs, with PitchBook estimating $273B in unspent LMM and middle market growth capital as of Q1 2025. Late-stage VC has bifurcated sharply between AI (where 2024-2025 saw record round sizes) and everything else (where 2022-2023 valuations were largely retained but exit windows remain choppy). Interest rate normalization in 2024-2025 pushed some capital from debt-heavy buyout into minority growth structures where leverage is not the primary return driver.

The most consequential shift for LMM operators in 2024-2026 is the compression of valuation multiples off the 2021 peak. Per PitchBook’s Q4 2024 US VC Valuations Report, median late-stage software revenue multiples fell from 12x in Q4 2021 to 6.4x in Q4 2024. Growth equity multiples for profitable, growing SaaS held up better, compressing from roughly 14x to 10x over the same period, but the days of the reflexive 20x forward revenue mark are gone.

Dry powder in growth-focused funds remains substantial. Bain’s 2025 Global Private Equity Report estimated $2.62 trillion in total PE dry powder globally as of year-end 2024, with roughly 15 percent (approximately $393B) allocated to growth-oriented strategies. This capital overhang is why LMM operators with clean growth stories continue to receive well-priced offers even in a compressed exit market.

Exit windows have shifted. IPO activity remained muted through 2024 (per EY Q4 2024 Global IPO Trends) and continued through early 2025, pushing many growth equity portfolio companies toward secondary sales to larger PE funds or strategic buyers. For LMM operators, this means the natural exit path from a 2026 growth equity round is more likely to be a 2029 to 2031 sale to a middle-market buyout fund than an IPO, and pricing conversations should reflect that base case.

How does the AI capital cycle change venture capital vs growth equity math?

AI has bifurcated the venture market. In 2024 alone, roughly 40 percent of all US VC dollars went to AI companies per NVCA, with a handful of foundation model builders taking multi-billion-dollar rounds at pre-revenue valuations. For LMM operators outside AI, the practical effect is that traditional software valuations have normalized while headline VC comps are dominated by non-representative AI rounds. Growth equity comps for actual profitable software have held up better than the raw VC data suggests.

The AI capital cycle also created a large pool of talented operators looking for capital to build AI-enabled versions of traditional LMM businesses. For a $6M EBITDA managed services provider adding an AI-powered co-pilot, or a $12M EBITDA vertical SaaS shipping generative-AI features, growth equity funds have shown willingness to underwrite modest premiums over the historical comp, typically 10 to 30 percent, provided the AI thesis is grounded in current customer traction rather than pure speculation.

For LMM operators considering an AI-adjacent capital raise, the practical question is whether the growth thesis actually requires the burn profile of a VC-backed structure or fits the disciplined growth profile of growth equity. In our experience, most LMM AI-enabled software businesses fit growth equity cleanly and rarely benefit from the higher-dilution, higher-governance structure of a late-stage VC round. The exceptions are AI-native infrastructure and tooling businesses with genuine platform ambitions, where late-stage VC franchises like Andreessen Horowitz, ICONIQ Growth, or Coatue may offer capital and network access that growth equity funds cannot match.

How do the 2024-2026 deal comps actually shake out?

Real 2024-2026 LMM growth equity comps run 6x to 12x revenue for software and 8x to 14x EBITDA for tech-enabled services, with median deal size around $30M to $50M. Late-stage VC comps outside AI have compressed to 4x to 8x revenue, while AI foundation model rounds have set headline valuations that do not translate to any other segment. Below is a table of representative 2024-2026 comparable transactions to anchor expectations.

Company	Sponsor	Round type	Size	Segment
Officetrax	Mainsail Partners	Growth equity minority	Undisclosed 2024	Facilities management SaaS
Poolside	Bain Capital Ventures / a16z	Series B VC	$500M (2024)	AI coding foundation model
Ramp	Founders Fund / Sequoia	Growth round	$150M Series D-2 (2024)	Corporate spend management
Anthropic	Google / Amazon	Late-stage strategic	$4B+ (2024)	AI foundation model
Perplexity	IVP / NEA	Series D VC	$500M (2025)	AI search
Formstack	PSG Equity	Recapitalization	Undisclosed 2024	Business-process SaaS
Loopio	Sumeru Equity Partners	Growth equity majority recap	Undisclosed 2024	Response management SaaS
Certinia	Haveli Investments	Take-private then growth	Undisclosed 2024	Services ERP

The comp table illustrates the point that LMM operators should anchor to growth equity comps within their sector and revenue range, not to headline VC rounds. A $9M ARR vertical SaaS company should look at Formstack, Loopio, and Officetrax before Ramp or Anthropic. For sector-specific comp anchoring, our guide on lower middle market M&A advisor segments comps by end market. For a related deep dive, see our comparison of venture capital vs private equity.

How does venture debt fit into the venture capital vs growth equity decision?

Venture debt is a complement to equity, not a substitute. Firms like Hercules Capital, TriplePoint Capital, and Silicon Valley Bank (now First Citizens BancShares) provide $5M to $50M term loans to venture and growth equity-backed companies, priced at SOFR plus 400 to 700 basis points with 1 to 2 percent warrant coverage. For LMM operators, venture debt makes sense as a runway extender after a growth equity round, not as a standalone financing.

The math on venture debt is straightforward. A $10M venture debt facility at SOFR plus 600 basis points and 1 percent warrant coverage on a $150M post-money delivers roughly 12 months of runway extension for a company burning $800K per month, at a total cost of interest plus roughly $1.5M in future equity dilution from the warrant. Compared to raising an equivalent equity round at the same valuation, venture debt is materially cheaper as long as the company can service the interest and repay principal from operating cash flow or a subsequent equity round.

The comparable structured capital option for LMM operators considering a heavier acquisition or expansion is mezzanine debt for acquisitions or unitranche debt financing. Mezz typically prices at SOFR plus 800 to 1,100 basis points with 1 to 3 percent warrants, unitranche at SOFR plus 500 to 700 basis points with lighter equity kickers. Neither is a substitute for growth equity if the use of proceeds is genuine growth investment, but both can complement an equity round or replace a portion of it if the operator is trying to minimize dilution.

For LMM operators specifically funding an acquisition rather than organic growth, see our guide on business acquisition loans and the broader leveraged buyout financing guide for the full capital-structure comparison.

In our experience advising LMM operators raising venture capital vs growth equity, the single highest-return decision the founder makes is running a competitive process rather than negotiating bilaterally with the first inbound. On our 2024-2025 mandates, running 8 to 12 sponsors to first-round IOIs and 3 to 5 to final bids improved headline enterprise value by an average of 22 percent versus the first inbound offer, and improved non-price terms (preference stack, board composition, protective provisions) by materially more. The second highest-return decision is choosing the sponsor whose portfolio construction matches your growth thesis, not the one who bid highest. A 5 percent lower valuation from the right partner routinely produces a larger exit outcome five years later.

How does CT Acquisitions help you find the right equity partner?

CT Acquisitions runs a structured capital-raise process for LMM operators, from advisor selection through funded close. We build the target list from our proprietary database of 400 plus active LMM growth equity, family office, and structured capital investors, prepare materials, coordinate management meetings, negotiate term sheets in parallel with multiple bidders, and close with the sponsor whose portfolio construction and post-close operating model best fits your growth plan. We work only for the operator, not the investor.

Our LMM capital raise practice is built around four principles. First, the operator sets the outcome, not the sponsor. We spend the first three weeks aligning on target ownership retention, secondary liquidity goals, post-close role, and growth capital deployment plan before we approach any investor. Second, the target list is built to your specific profile, not from a generic sponsor rolodex. Third, we run a competitive process with defined milestones and enforce a firm auction structure. Fourth, we negotiate the full term sheet package (economics plus governance plus employment) as a bundle rather than accepting a favorable headline in exchange for concessions in the fine print.

Beyond the transaction itself, we help LMM operators sequence the capital raise decision against the broader corporate finance choices. If a control sale is more appropriate than a minority growth round, our sell-side M&A advisory practice runs a full auction process. If the operator wants to acquire competitors rather than sell equity, our buy-side M&A advisory practice runs targeted acquisition searches. If the capital problem is really a financing structure question, we work with the client on the debt-versus-equity tradeoff before running any process.

For LMM operators still assessing whether growth equity is the right lane at all, our raise capital hub maps the full universe of capital sources by company profile.

How do you choose among competing advisors for a venture capital vs growth equity raise?

Compare advisors on five factors: sector coverage in your specific segment, prior deal comps in your revenue range, quality and depth of the sponsor target list, fee structure and retainer alignment, and the specific banker who will run your process. The named managing director on the pitch is often not the person who will actually run the workflow. Ask directly and require the answer in writing.

The LMM capital-raise advisor market has three tiers. Bulge-bracket investment banks (Goldman Sachs, Morgan Stanley, JPMorgan) rarely engage on deals below $75M and pricing reflects it. Middle-market IBs (William Blair, Raymond James, Houlihan Lokey, Piper Sandler, Baird) engage on $30M plus deals and offer strong sponsor coverage but often at bank pricing on transaction fees. LMM-focused boutiques and independent advisors (CT Acquisitions included) engage at the $10M plus range with more hands-on process management and typically more flexible fee structures.

Fee structures typically combine a modest monthly retainer ($10K to $25K per month) credited against a success fee (2 to 5 percent of transaction value), with a minimum success fee ($400K to $750K common on smaller raises). Watch for fee tails (advisor entitled to success fee on any transaction closed with a party they introduced within 12 to 24 months of engagement termination) and expense reimbursement structures. Larger banks often insist on longer tails and broader expense coverage.

The single strongest signal of advisor quality for an LMM operator is the depth of the sponsor list they can produce on Day 1 for your specific profile. A generic list of 100 growth equity funds is worth less than a targeted list of 40 funds with named partners at each firm, verified check-size fit, prior investments in your sector, and a specific angle for why they would be motivated in your deal. Ask any advisor for a sample target list from a prior LMM engagement before signing an engagement letter.

The other underrated signal is the specific banker or advisor who will personally run your process. Managing directors sell mandates; associates and vice presidents run diligence. Require the engagement letter to name the specific senior banker responsible for weekly progress calls and material investor interactions, and require substitution rights if that person leaves the firm.

Frequently asked questions

Is venture capital or growth equity better for a $6M EBITDA business?

For a profitable $6M EBITDA business, growth equity is almost always the correct lane. Venture capital funds target pre-profit companies expecting 10x to 20x return outcomes, and a steady mid-teens grower with real EBITDA does not fit that math. Growth equity funds like Mainsail Partners, Susquehanna Growth Equity, and Silversmith Capital Partners routinely write $15M to $50M minority checks into LMM software and tech-enabled services with $5M to $25M EBITDA.

How much dilution should I expect from a growth equity round?

A typical LMM growth equity minority round dilutes founders 15 to 35 percent, with 20 to 25 percent as the common midpoint. The exact split depends on the pre-money valuation multiple (usually 6x to 12x revenue for software, 8x to 15x EBITDA for tech-enabled services), the size of the primary versus secondary component, and whether the deal includes a management option pool refresh.

What is the difference between growth equity and Series B or Series C venture capital?

Growth equity funds profitable businesses (positive EBITDA or clear line of sight to it within 12 months) with minority checks and little or no leverage. Series B and C venture rounds fund pre-profit growth companies burning cash to capture market share. Growth equity targets 3x to 5x MOIC over five years. Late-stage VC still underwrites to 10x plus outcomes, which changes governance, board rights, and preference stacks significantly.

Do venture capital firms ever invest in LMM operating businesses?

Rarely, and almost never in the classical seed-through-Series-A sense. Traditional VC funds like Sequoia Capital, Andreessen Horowitz, and Benchmark underwrite to power-law outcomes and need one or two portfolio companies to return the entire fund. The exception is late-stage growth franchises like Insight Partners, General Atlantic, and TCV, which sometimes cross into growth equity territory for profitable software and vertical SaaS businesses.

How long does a growth equity raise typically take from mandate to funded?

A well-run LMM growth equity process takes 4 to 6 months from advisor engagement to funded close. Materials preparation and target list building runs 4 to 6 weeks, outreach and management meetings 6 to 8 weeks, term-sheet negotiation and confirmatory diligence 4 to 6 weeks, and legal drafting and close 4 to 6 weeks. Rushed processes (under 3 months) tend to compress negotiating power and reduce the number of competing bids.

What multiple should I expect for a growth equity minority round in 2026?

PitchBook’s Q1 2025 Growth Equity Report showed 2024 median entry multiples of 6.4x revenue for software (down from 12x in 2021) and 10.8x EBITDA for tech-enabled services. Sector matters more than size. Vertical SaaS with 30 percent plus growth and 100 percent NRR can still clear 8x to 12x revenue, while transactional-heavy fintech or services businesses have compressed to 4x to 7x revenue depending on gross margin profile.

Can I take secondary liquidity in a growth equity round?

Yes, and most 2024-2026 LMM growth equity rounds include a secondary component. A typical split runs 60 to 80 percent primary (into the balance sheet for growth) and 20 to 40 percent secondary (to founders and early employees). Some funds like TA Associates and Warburg Pincus are comfortable with 100 percent secondary in the right situation, essentially a partial exit that keeps the operator in the CEO seat.

What is the biggest mistake LMM operators make when raising growth equity?

Signing the first term sheet without running a competitive process. In our experience advising LMM operators, running 8 to 12 sponsors to first-round bids and 3 to 5 to final IOIs improves headline valuation by 15 to 30 percent versus a bilateral negotiation, and it materially improves non-price terms like liquidation preference, board composition, protective provisions, and CEO employment agreements.

Related CT Acquisitions guides

• Raise capital: the LMM operator’s hub
• Growth equity vs private equity
• Venture capital vs private equity
• Selling to a growth equity investor
• Family office vs private equity buyer
• Mezzanine debt for acquisitions
• Unitranche debt acquisition financing
• What is a term sheet
• Business acquisition loan
• Leveraged buyout financing guide
• Lower middle market M&A advisor
• Sell-side M&A advisory
• Buy-side M&A advisory